Genotyping Market Forecast to 2028

Genotyping Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology (Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), End-User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other), and Geography

Report Code : TIPHE100001166 | Region : Global | Industry : Pharmaceuticals | Published Date : 29/Jun/2022

The global genotyping market is expected to grow from US$ 25,191.28 million in 2022 to US$ 79,407.14 million by 2028; it is expected to grow with a CAGR of 21.1% from 2022 to 2028.

The use of genotyping in drug development for genetic & rare diseases and rising R&D investments in pharmaceutical & biotechnology boost the global genotyping market growth.

Genotyping compares a DNA sequence to another sample or a reference sequence to discover variations in genetic complement. It detects single-nucleotide polymorphisms (SNPs), which are minor differences in genetic sequence within the population. The human genome has about 660 million SNPs, making them the most prevalent kind of genetic variation. They can explain features such as eye color and hereditary disorders such as cystic fibrosis and sickle cell anemia and serve as indicators for developing complicated diseases such as cancer, diabetes, and Alzheimer's. According to the GLOBOCAN database published in 2020, an estimated 28.4 million new cancer cases are predicted to occur in 2040, a 47% increase from the corresponding 19.3 million cases in 2020.

According to the Alzheimer’s Association, in 2022, the number of people living with Alzheimer’s in the US rapidly increases. Alzheimer’s affects more than 6 million Americans of all ages. In 2022, an estimated 6.5 million Americans aged 65 and up have Alzheimer's, out of which 73% of the population is 75 years old or older.

According to the International Diabetes Federation (IDF) consortium, in 2019, type 2 diabetes (T2D) is one of the leading causes of death worldwide, accounting for 4.2 million deaths in 2019. According to the same research, Iran ranks third among 20 countries in the Middle East and North Africa (MENA) in terms of the number of adults with diabetes (5.4 million), estimated that about 9.2 million Iranians may catch the disease by 2030. Type 2 diabetes is a complex metabolic illness caused by genetic and non-genetic (environmental) factors. The heritability of T2D varies between 20% and 80%, indicating that genetic factors play a significant part in the disease's development; the disease's heritable component is polygenic, meaning that multiple genes and their variations contribute to an increased risk of T2D development. The introduction of high-throughput genotyping technologies has greatly advanced our understanding of the genetic components of complex disorders, such as T2D.

Additionally, by comparing polymorphisms in two distinct populations (one healthy and one diseased), genome-wide association studies (GWAS) can uncover links between SNPs and common illness risk.

GWAS can begin to untangle the molecular mechanisms underlying disease states by finding probable causative variables risk stratification. Single-celled organisms, such as bacteria, even have SNPs. SNP genotyping can discriminate between microorganism isolates and might even be accustomed to characterizing antibiotic resistance strains. SNP-based strain detection has relevance in each clinical and pharmaceutical analysis and has been used to study the spread of infectious diseases in humans.

As per the Global Genes Project, 2017, up to 350 million people worldwide suffer from rare diseases. Although individual diseases are rare, they pose significant challenges to the global healthcare system. As per the WHO, in 2020, more than 1.7 million children in India were born with congenital disabilities for which genetic or chromosomal abnormalities are the major causal agent.

Since these conditions are difficult to identify clinically, genotyping is the backbone of diagnostic testing in the population. This rising adoption of prenatal genetic screening to examine children's chromosomal anomalies could prove to be a major driving factor.

Over the last decade, next-generation sequencing (NGS) technology has enabled simultaneous testing of multiple disease genes, from targeted gene panels to exome sequencing (ES) and genomic sequencing (GS). GS is quickly becoming a practical first-stage test as costs decrease and performance improves. More and more studies show that GS can detect an unprecedented range of pathogenic abnormalities in a single laboratory. GS has the potential to provide patients with unbiased, rapid, and accurate molecular diagnostics that transcend diverse clinical indications and complex conditions. Therefore, the use in drug development for genetic and rare diseases across the globe will act as one of the key factors driving the growth of the genotyping markets.

The genotyping market witnessed a surge in the COVID-19 crisis owing to increased demand for COVID-19 genotyping kits. Single nucleotide polymorphism (SNP) genotyping has been used to detect genetic variants of the Covid-19 virus. As the SARS-CoV-2 virus continues to evolve, variants of concern (VOC) could increase transmissibility and impair the efficacy of COVID-19 vaccines. As a response, physicians across the globe began genotyping SARS-CoV-2 variations.

The COVID-19 pandemic increased the demand for genotyping-based research activities to develop COVID diagnostics, vaccines, and therapeutics. Scientists from Brazil and the UK formed the Center for Arbovirus Discovery, Diagnosis, Genomics, and Epidemiology (CADDE) team. Within 48 hours of the first verified case in early March 2020, the team in Brazil sequenced the genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Further, increased product launches such as reagents & kits, bioinformatics, and genotyping services. For instance, In March 2020, Singapore-listed medtech company Biolidics launched its rapid test kit for COVID-19 detection. A manufacturing agreement was made with a manufacturer of a diagnostic kit manufacturer to customize and manufacture the rapid test kits. Biolidics has obtained provisional authorization from Singapore's Health Science Authority (HSA) for its rapid test kit to be used in Singapore.

In addition, In June 2022, CoviEasy "At-Home" self-test kit for COVID-19 was introduced by Genes2Me. One of the top IVD solution manufacturers in India, Genes2Me Pvt. Ltd., launched their CoviEasy Self-Test Rapid Antigen test kit for COVID-19, which is simple to use and provides fast results in 10 minutes. This IVD device offers high sensitivity and concordance of more than 90% accuracy and is supported by an AI-driven mobile app. Thus, the pandemic had a positive impact on the genotyping market.

Based on product and service, the genotyping market is segmented into instruments, reagents & kits, bioinformatics, and genotyping services. In 2022, the reagents and kits segment is estimated to hold the largest share of the market. The same segment is expected to register the highest CAGR from 2022 to 2028.

Based on technology, the genotyping market is segmented into microarrays, capillary electrophoresis, sequencing, matrix-assisted laser desorption/ionization-time of flight (Maldi-ToF), and mass spectrometry, polymerase chain reaction (PCR), and others. In 2022, the polymerase chain reaction (PCR) segment is estimated to hold the largest share of the market. The same segment is expected to register the highest CAGR from 2022 to 2028.

Based on application, the genotyping market is segmented into pharmacogenomics, diagnostics & personalized medicine, animal genetics, agricultural biotechnology, and others. In 2022, the diagnostics & personalized medicine segment is expected to account for the largest share of the market. Moreover, the pharmacogenomics segment is expected to register the highest CAGR from 2022 to 2028.

Based on end user, the genotyping market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others. In 2022, the diagnostic and research laboratories segment is expected to account for the largest share of the market. Moreover, the pharmaceutical and biopharmaceutical companies segment is expected to register the highest CAGR from 2022 to 2028

National Science Foundation (NSF), Gene People, Globocan, World Health Organization (WHO), National Science Foundation (NSF), International Trade Administration US Department of Commerce, Department of Emergency Medicine, Alzheimer’s Association, International Diabetes Federation (IDF), National Health Service of England, US Centers for Medicare & Medicaid Services, The Spanish Association of Biotech companies (ASEBIO), are among the primary and secondary sources referred to while preparing the report on the genotyping market.

Polymerase Chain Reaction (PCR) Segment to Lead Genotyping Market During 2022–2028

According to our latest study on “Genotyping Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product and Service, Technology, Application, End-User, and Geography," the market is expected to reach US$ 79,407.14 million in 2028 from US$ 25,191.28 million in 2022; it is estimated to grow at a CAGR of 20.9% during 2022–2028. The report highlights the key factors driving the Genotyping market growth and prominent players with their developments in the Genotyping market.

Genotyping is identifying the DNA sequence, or genotype, at particular locations across an individual's genome. In linkage and association studies, sequence variations can be employed as markers to find the genes responsible for specific characteristics or diseases. Understanding the relationship between genotypes and phenotypes requires knowledge of genotyping. Compared to a reference sequence from the general population or a specific subgroup, an individual genome is recognized as a distinct variant. The growth of the Genotyping market is primarily attributed to the use of genotyping in drug development for genetic and rare diseases, technological advancements, and rising R&D investments in pharmaceutical and biotechnology. However, the high equipment cost and the shortage of skilled professionals are expected to restrict the market growth during the forecast period.

The global Genotyping market, based on technology, is segmented into microarrays, capillary electrophoresis, sequencing, matrix-assisted laser desorption/ionization-time of flight (Maldi-ToF) mass spectrometry, polymerase chain reaction, others. In 2022, the polymerase chain reaction (PCR) segment will likely hold the market's largest share. Further, the sequencing segment is expected to witness growth in demand at the fastest CAGR from 2022 to 2028, owing to its higher specificity and capacity to detect the low expression and differentially expressed genes. Various pharmaceutical and biopharmaceutical companies offer PCR solutions for pharmacogenomic and drug development applications, and rapid product launches will further drive the market’s growth. For instance, Thermo Fisher Scientific, Inc offers a real-time PCR solution for the pharmacogenomic application, which works by combining the power of QuantStudio 12K Flex Real-time PCR System with qualified TaqMan genotyping assays. On June 02, 2022, the CFX Duet Real-Time PCR System was launched by Bio-Rad Laboratories.

F. Hoffmann-La Roche Ltd., Integrated DNA Technologies, Inc. (Danaher), Qiagen, Merck KGaA, Eurofins Genomics, Thermo Fisher Scientific Inc., BioTek Instruments, Inc., Xcelris Genomics, Trimgen Corporation, and Illumina, Inc. are a few leading companies operating in the global Genotyping market are among the key players operating in the Genotyping market. For instance, in January 2021, Thermo Fisher Scientific Inc. launched the Orbitrap Exploris MX Mass Detector for new-generation mass spectrometry instruments, workflows, and software. 

Genotyping Market, by Technology, 2022 (%)

Source: The Insight Partners Analysis

The report segments the Genotyping market as follows:

Based on product and services, the market is segmented into reagents and kits, bioinformatics, genotyping services, and instruments. Based on Technology, the market is segmented into Microarrays, Capillary Electrophoresis, Sequencing, Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-ToF) Mass Spectrometry, Polymerase Chain Reaction (PCR) & Others. Based on Application, the market is segmented into Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology & Others. Based on End-User, the global Genotyping market is segmented into Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes & Others. Based on geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Genotyping Market – By Product and Service

1.3.2 Global Genotyping Market – By Technology

1.3.3 Global Genotyping Market – By Application

1.3.4 Global Genotyping Market – By End-User

1.3.5 Global Genotyping Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Genotyping Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East and Africa PEST Analysis

4.2.5 South and Central America PEST Analysis

4.3 Experts Opinion

5. Genotyping Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Use of Genotyping in Drug Development for Genetic and Rare Diseases

5.1.2 Technological Advancements and Rising R&D Investments in Pharmaceutical and Biotechnology

5.2 Market Restraints

5.2.1 High Cost of Equipment and Shortage of skilled Professionals required for Genotyping process

5.3 Market Opportunities

5.3.1 Wide Applications of Genotyping

5.4 Future Trends

5.4.1 Rising focus on Personalized Medicine

5.5 Impact analysis

6. Genotyping Market– Global Analysis

6.1 Global Genotyping Market Revenue Forecast and Analysis

6.2 Global Genotyping Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

6.4 Global Genotyping Market – Market Potential Analysis, By Region

6.5 Comparative Company Analysis

6.6 Growth Strategy Analysis

6.7 Performance of Key Players

6.7.1.1 F. Hoffmann-La Roche Ltd.

6.7.1.2 Illumina, Inc.

6.8 Market Share Analysis of Genotyping Market

7. Global Genotyping Market Revenue and Forecasts To 2028– by Product and Service

7.1 Overview

7.2 Global Genotyping Market, By Product and Service, 2022 & 2028 (%)

7.3 Reagents and Kits

7.3.1 Overview

7.3.2 Reagents and Kits: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Genotyping Services

7.4.1 Overview

7.4.2 Genotyping Services: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Bioinformatics

7.5.1 Overview

7.5.2 Bioinformatics: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Instruments

7.6.1 Overview

7.6.2 Instruments: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

8. Genotyping Market Revenue and Forecasts To 2028 – Technology

8.1 Overview

8.2 Global Genotyping Market Share by Technology - 2022 & 2028 (%)

8.3 Polymerase Chain Reaction (PCR)

8.3.1 Overview

8.3.2 Polymerase Chain Reaction: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

8.4 Capillary Electrophoresis (CE)

8.4.1 Overview

8.4.2 Capillary Electrophoresis: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

8.5 Sequencing

8.5.1 Overview

8.5.2 Sequencing: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

8.6 Microarrays

8.6.1 Overview

8.6.2 Microarrays: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

8.7 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry

8.7.1 Overview

8.7.2 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

9. Genotyping Market Revenue and Forecasts To 2028 – Application

9.1 Overview

9.2 Global Genotyping Market Share by Application - 2022 & 2028 (%)

9.3 Diagnostics and Personalized Medicine

9.3.1 Overview

9.3.2 Diagnostics and Personalized Medicine: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

9.4 Pharmacogenomics

9.4.1 Overview

9.4.2 Pharmacogenomics: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

9.5 Animal Genetics

9.5.1 Overview

9.5.2 Animal Genetics: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

9.6 Agricultural Biotechnology

9.6.1 Overview

9.6.2 Agricultural Biotechnology: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

10. Genotyping Market Revenue and Forecasts To 2028 – End-User

10.1 Overview

10.2 Global Genotyping Market Share by End User- 2022 & 2028 (%)

10.3 Diagnostic and Research Laboratories

10.3.1 Overview

10.3.2 Diagnostic and Research Laboratories: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

10.4 Pharmaceutical and Biopharmaceutical Companies

10.4.1 Overview

10.4.2 Pharmaceutical and Biopharmaceutical Companies: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

10.5 Academic Institutes

10.5.1 Overview

10.5.2 Academic Institutes: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

11. Genotyping Market Revenue and Forecasts to 2028 – Geographical Analysis

11.1 North America: Genotyping Market Revenue and Forecasts To 2028

11.1.1 Overview

11.1.2 North America: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3 North America: Genotyping Market, by Product and Services, 2019–2028 (US$ Million)

11.1.4 North America: Genotyping Market, by Technology, 2019–2028 (US$ Million)

11.1.5 North America: Genotyping Market, by Application, 2019–2028 (US$ Million)

11.1.6 North America: Genotyping Market, by End User, 2019–2028 (US$ Million)

11.1.7 North America: Genotyping Market, by Country, 2022 & 2028 (%)

11.1.7.1 US: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.1 Overview

11.1.7.1.2 US: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.3 US: Genotyping Market, by Product and Services, 2019–2028 (US$ Million)

11.1.7.1.4 US: Genotyping Market, by Technology, 2019–2028 (US$ Million)

11.1.7.1.5 US: Genotyping Market, by Application, 2019–2028 (US$ Million)

11.1.7.1.6 US: Genotyping Market, by End User, 2019–2028 (US$ Million)

11.1.7.2 Canada: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.1 Overview

11.1.7.2.2 Canada: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.3 Canada: Genotyping Market, by Product and Services, 2019–2028 (US$ Million)

11.1.7.2.4 Canada: Genotyping Market, by Technology, 2019–2028 (US$ Million)

11.1.7.2.5 Canada: Genotyping Market, by Application, 2019–2028 (US$ Million)

11.1.7.2.6 Canada: Genotyping Market, by End User, 2019–2028 (US$ Million)

11.1.7.3 Mexico: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.1 Overview

11.1.7.3.2 Mexico: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.3 Mexico: Genotyping Market, by Product and Services, 2019–2028 (US$ Million)

11.1.7.3.4 Mexico: Genotyping Market, by Technology, 2019–2028 (US$ Million)

11.1.7.3.5 Mexico: Genotyping Market, by Application, 2019–2028 (US$ Million)

11.1.7.3.6 Mexico: Genotyping Market, by End User, 2019–2028 (US$ Million)

11.2 Europe: Genotyping Market

11.2.1 Overview

11.2.2 Europe: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.3 Europe: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

11.2.4 Europe: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

11.2.5 Europe: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

11.2.6 Europe: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.2.7 Europe: Genotyping Market, by Country, 2021 & 2028 (%)

11.2.7.1 Germany: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.1 Overview

11.2.7.1.2 Germany: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.3 Germany: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.4 Germany: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.5 Germany: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

11.2.7.1.6 Germany: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.2.7.2 France: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.1 Overview

11.2.7.2.2 France: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.3 France: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.4 France: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.5 France: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

11.2.7.2.6 France: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.2.7.3 UK: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.1 Overview

11.2.7.3.2 UK: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.3 UK: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.4 UK: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.5 UK: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

11.2.7.3.6 UK: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.2.7.4 Italy: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.1 Overview

11.2.7.4.2 Italy: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.3 Italy: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.4 Italy: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.5 Italy: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

11.2.7.4.6 Italy: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.2.7.5 Spain: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.1 Overview

11.2.7.5.2 Spain: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.3 Spain: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.4 Spain: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.5 Spain: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

11.2.7.5.6 Spain: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.2.7.6 Rest of Europe: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.1 Overview

11.2.7.6.2 Rest of Europe: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.3 Rest of Europe: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.4 Rest of Europe: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.5 Rest of Europe: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

11.2.7.6.6 Rest of Europe: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.3 Asia Pacific Genotyping Market Revenue and Forecasts To 2028

11.3.1 Overview

11.3.2 Asia Pacific Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.3.3 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

11.3.4 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.3.5 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.3.6 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

11.3.7 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Country (%)

11.3.7.1 Japan: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.1.1 Overview

11.3.7.1.2 Japan: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.1.3 Japan: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

11.3.7.1.4 Japan: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.3.7.1.5 Japan: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.3.7.1.6 Japan: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

11.3.7.2 China: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.2.1 Overview

11.3.7.2.2 China: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.2.3 China: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

11.3.7.2.4 China: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.3.7.2.5 China: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.3.7.2.6 China: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

11.3.7.3 India Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.3.1 Overview

11.3.7.3.2 India: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.3.3 India: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

11.3.7.3.4 India: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.3.7.3.5 India: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.3.7.3.6 India: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

11.3.7.4 South Korea: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.4.1 Overview

11.3.7.4.2 South Korea: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.4.3 South Korea: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

11.3.7.4.4 South Korea: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.3.7.4.5 South Korea: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.3.7.4.6 South Korea: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

11.3.7.5 Australia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.5.1 Overview

11.3.7.5.2 Australia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.3.7.5.3 Australia: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

11.3.7.5.4 Australia: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.3.7.5.5 Australia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.3.7.5.6 Australia: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

11.3.7.6 Rest of Asia Pacific: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.3.7.6.1 Overview

11.3.7.6.2 Rest of Asia Pacific: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

11.3.7.6.3 Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

11.3.7.6.4 Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.3.7.6.5 Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.3.7.6.6 Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

11.4 Middle East & Africa Genotyping Market Revenue and Forecasts To 2028

11.4.1 Overview

11.4.2 Middle East & Africa Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.4.3 Middle East & Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

11.4.4 Middle East & Africa: Genotyping Market, by Technology, 2019–2028 (US$ Million)

11.4.5 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.4.6 Middle East & Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.4.7 Middle East & Africa Genotyping Market Revenue and Forecasts to 2028, By Country (%)

11.4.7.1 UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.1.1 Overview

11.4.7.1.2 UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.1.3 UAE: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

11.4.7.1.4 UAE: Genotyping Market, by Technology, 2019–2028 (US$ Million)

11.4.7.1.5 UAE: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)

11.4.7.1.6 UAE: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.4.7.2 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.2.1 Overview

11.4.7.2.2 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.2.3 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

11.4.7.2.4 Saudi Arabia: Genotyping Market, by Technology, 2019–2028 (US$ Million)

11.4.7.2.5 Saudi Arabia: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)

11.4.7.2.6 Saudi Arabia: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.4.7.3 South Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.3.1 Overview

11.4.7.3.2 South Africa Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.3.3 South Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

11.4.7.3.4 South Africa: Genotyping Market, by Technology, 2019–2028 (US$ Million)

11.4.7.3.5 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)

11.4.7.3.6 South Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.4.7.4 Rest of Middle East and Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.4.1 Overview

11.4.7.4.2 Rest of Middle East and Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.4.7.4.3 Rest of Middle East & Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

11.4.7.4.4 Rest of Middle East & Africa: Genotyping Market, by Technology, 2019–2028 (US$ Million)

11.4.7.4.5 Rest of Middle East & Africa: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)

11.4.7.4.6 Rest of Middle East and Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.5 South And Central America Genotyping Market Revenue and Forecasts To 2028

11.5.1 Overview

11.5.2 South and Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.5.3 South and Central America Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

11.5.4 South and Central America: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.5.5 South and Central America: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.5.6 South and Central America: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

11.5.7 South and Central America Genotyping Market Revenue and Forecasts to 2028, By Country (%)

11.5.7.1 Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.5.7.1.1 Overview

11.5.7.1.2 Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.5.7.1.3 Argentina: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

11.5.7.1.4 Argentina: Genotyping Market Revenue and Forecasts To 2028, By Technology (US$ Million)

11.5.7.1.5 Argentina: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)

11.5.7.1.6 Argentina: Genotyping Market Revenue and Forecasts To 2028, By End User (US$ Million)

11.5.7.2 Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.5.7.2.1 Overview

11.5.7.2.2 Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.5.7.2.3 Brazil: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

11.5.7.2.4 Brazil: Genotyping Market Revenue and Forecasts To 2028, By Technology (US$ Million)

11.5.7.2.5 Brazil: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)

11.5.7.2.6 Brazil: Genotyping Market Revenue and Forecasts To 2028, By End User (US$ Million)

11.5.7.3 Rest of South and Central America: Genotyping Market– Revenue and Forecast to 2028 (USD Mn)

11.5.7.3.1 Overview

11.5.7.3.2 Rest of South and Central America: Genotyping Market– Revenue and Forecast to 2028 (USD Mn)

11.5.7.3.3 Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

11.5.7.3.4 Rest of South & Central America: Genotyping Market Revenue and Forecasts To 2028, By Technology (US$ Million)

11.5.7.3.5 Rest of South & Central America: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)

11.5.7.3.6 Rest of South & Central America: Genotyping Market Revenue and Forecasts To 2028, By End User (US$ Million)

12. Impact Of COVID-19 Pandemic on Genotyping Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

12.2 Europe: Impact Assessment of COVID-19 Pandemic

12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12.5 South and Central America: Impact Assessment of COVID-19 Pandemic

13. Genotyping Market Industry Landscape

13.1 Overview

13.2 Growth Strategies Done by the Companies in the Market, (%)

13.3 Organic Developments

13.3.1 Overview

13.4 Inorganic Developments

13.4.1 Overview

14. Company Profiles

14.1 F. HOFFMANN-LA ROCHE LTD.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 INTEGRATED DNA TECHNOLOGIES, INC. (DANAHER)

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 QIAGEN

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 MERCK KGaA

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 EUROFINS GENOMICS

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 THERMO FISHER SCIENTIFIC INC.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 BioTek Instruments, Inc.

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 XCELRIS GENOMICS

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 TRIMGEN CORPORATION

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Financial Overview

14.9.4 SWOT Analysis

14.9.5 Key Developments

14.10 Illumina, Inc.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES.

Table 1. The pharmaceutical company partnered with genomic health databases

Table 2. North America Genotyping Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 4. North America Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 5. North America Genotyping Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 6. US Genotyping Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

Table 7. US Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 8. US Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 9. US Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10. Canada: Genotyping Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 14. Mexico: Genotyping Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

Table 15. Mexico: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 16. Mexico Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 17. Mexico Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 18. Europe: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

Table 19. Europe: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 20. Europe: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 21. Europe: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22. Germany: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

Table 23. Germany: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 24. Germany: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 25. Germany: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 26. France: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

Table 27. France: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 28. France: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 29. France: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 30. UK: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

Table 31. UK: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 32. UK: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 33. UK: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 34. Italy: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

Table 35. Italy: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 36. Italy: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 37. Italy: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 38. Spain: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

Table 39. Spain: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 40. Spain: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 41. Spain: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 42. Rest of Europe: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)

Table 43. Rest of Europe: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 44. Rest of Europe: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 45. Rest of Europe: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 46. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million).

Table 47. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 48. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 49. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 50. Japan: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

Table 51. Japan: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 52. Japan: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 53. Japan: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 54. China: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

Table 55. China: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 56. China: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 57. China: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 58. India: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

Table 59. India: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 60. India: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 61. India: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 62. South Korea: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

Table 63. South Korea: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 64. South Korea: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 65. South Korea: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 66. Australia: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

Table 67. Australia: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 68. Australia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 69. Australia: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 70. Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

Table 71. Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 72. Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 73. Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 74. Middle East & Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

Table 75. Middle East & Africa: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 76. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 77. Middle East & Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 78. UAE: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

Table 79. UAE: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 80. UAE: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 81. UAE: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 82. Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

Table 83. Saudi Arabia: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 84. Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 85. Saudi Arabia: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 86. South Africa Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

Table 87. South Africa: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 88. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 89. South Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 90. Rest of Middle East & Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

Table 91. Rest of Middle East & Africa: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 92. Rest of Middle East & Africa: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 93. Rest of Middle East and Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 94. South and Central America Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

Table 95. South and Central America: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 96. South and Central America: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 97. South and Central America: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 98. Argentina: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

Table 99. Argentina: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 100. Argentina: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 101. Argentina: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 102. Brazil: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

Table 103. Brazil: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 104. Brazil: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 105. Brazil: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 106. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)

Table 107. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Technology ( US$ Million)

Table 108. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 109. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 110. Organic Developments Done By Companies

Table 111. Inorganic Developments Done By Companies

Table 112. Glossary of Terms

LIST OF FIGURES.

Figure 1. Genotyping Market Segmentation

Figure 2. Genotyping Market – By Geography

Figure 3. Genotyping Market Overview

Figure 4. Reagents and Kits Held Largest Share by Product and Services of Genotyping Market

Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

Figure 6. Genotyping Market, by Geography (US$ Million)

Figure 7. Global Genotyping Market – Leading Country Markets (US$ Million)

Figure 8. Global Genotyping Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East and Africa: PEST Analysis

Figure 13. South and Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Genotyping Market Impact Analysis of Driver and Restraints

Figure 16. Global Genotyping Market– Revenue Forecast and Analysis – 2022 - 2028

Figure 17. Global Genotyping Market – By Geography Forecast and Analysis – 2022 - 2028

Figure 18. Market Positioning of Key Players in Genotyping Market

Figure 19. Global Genotyping Market – Market Potential Analysis, By Region

Figure 20. Global Genotyping Market – Comparative Company Analysis

Figure 21. Global Genotyping Market – Growth Strategy Analysis

Figure 22. Market Share Analysis of Key Players in Global Genotyping Market

Figure 23. Global Genotyping Market, by Product and Service, 2022 & 2028 (%)

Figure 24. Reagents and Kits: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Genotyping Services: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Bioinformatics: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Instruments: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Global Genotyping Market Share by Technology - 2022 & 2028 (%)

Figure 29. Polymerase Chain Reaction: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30. Capillary Electrophoresis: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31. Sequencing: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32. Microarrays: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 33. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34. Others: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 35. Global Genotyping Market Share by Application - 2022 & 2028 (%)

Figure 36. Diagnostics and Personalized Medicine: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 37. Pharmacogenomics: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 38. Animal Genetics: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 39. Agricultural Biotechnology: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 40. Others: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 41. Global Genotyping Market Share by End User- 2022 & 2028 (%)

Figure 42. Diagnostic and Research Laboratories: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 43. Pharmaceutical and Biopharmaceutical Companies: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 44. Academic Institutes: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 45. Others: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)

Figure 46. North America: Genotyping Market, by Key Country – Revenue (2021) (US$ Million)

Figure 47. North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

Figure 48. North America: Genotyping Market, by Country, 2022 & 2028 (%)

Figure 49. US: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

Figure 50. Canada: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

Figure 51. Mexico: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

Figure 52. Europe: Genotyping Market, by Key Country – Revenue (2021) (US$ Million)

Figure 53. Europe: Genotyping Market Revenue and Forecast to 2028 (US$ Million)

Figure 54. Europe: Genotyping Market, by Country, 2021 & 2028 (%)

Figure 55. Germany: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

Figure 56. France: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

Figure 57. UK: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

Figure 58. Italy: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

Figure 59. Spain: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

Figure 60. Rest of Europe: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

Figure 61. Asia Pacific Genotyping Market Overview, by Country (2021)

Figure 62. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 63. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Country (%)

Figure 64. Japan: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 65. China: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 66. India: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 67. South Korea: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 68. Australia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 69. Rest of Asia Pacific: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)

Figure 70. Middle East & Africa Genotyping Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 71. Middle East & Africa Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 72. Middle East & Africa Genotyping Market Revenue and Forecasts to 2028, By Country (%)

Figure 73. UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 74. Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 75. South Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 76. Rest of Middle East and Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 77. South and Central America Genotyping Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 78. South and Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 79. South and Central America Genotyping Market Revenue and Forecasts to 2028, By Country (%)

Figure 80. Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 81. Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 82. Rest of South and Central America: Genotyping Market– Revenue and Forecast to 2028 (US$ Mn)

Figure 83. Impact of COVID-19 Pandemic in North American Country Markets

Figure 84. Impact of COVID-19 Pandemic in European Country Markets

Figure 85. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 86. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 87. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

Figure 88. Growth Strategies Done by the Companies in the Market, (%)

List of Companies:

1. F. Hoffmann-La Roche Ltd.

2. Integrated DNA Technologies, Inc.

3. QIAGEN

4. MERCK KGaA

5. Eurofins Genomics

6. Thermo Fisher Scientific Inc

7. BioTek Instruments, Inc.

8. Xcelris Genomics

9. TrimGen Corporation

10. Illumina, Inc.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the genotyping market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global genotyping market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the genotyping market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

TOP